Potassium 5-methyl-2-thiophene
Product Information
Molecular Formula
CH3C4H2SBF3K
Molecular Weight
204.06
Description
Potassium 5-methyl-2-thiophene is utilized in the biomedical industry for its potential therapeutic applications. It is integrated into drugs aiming to treat various diseases, such as cancer, inflammation, and neurological disorders. Its molecular structure and properties make it an essential component in developing medications that combat these specific conditions effectively.
Synonyms
Potassium 5-methyl-2-thiophene; Potassium 5-methyl-2-thiophenetrifluoroborate
IUPAC Name
potassiumtrifluoro-(5-methylthiophen-2-yl)boranuide
SMILES
[B-](C1=CC=C(S1)C)(F)(F)F.[K+]
InChI
InChI=1S/C5H5BF3S.K/c1-4-2-3-5(10-4)6(7,8)9/h2-3H,1H3/q-1+1
InChI Key
SLHDDEQSKNIZEL-UHFFFAOYSA-N
Melting Point
>220 °C
Purity
95%
Safety Information
Hazards
H315-H319-H335
Precautionary Statement
P261-P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
0
Exact Mass
203.9794175 g/mol
Monoisotopic Mass
203.9794175 g/mol
Topological Polar Surface Area
28.2Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
129
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2015233654-A1 | Heteroaryl Syk inhibitors | 2014-03-19 |
| AU-2015233654-B2 | Heteroaryl Syk inhibitors | 2014-03-19 |
| CA-2942997-A1 | Heteroaryl syk inhibitors | 2014-03-19 |
| CN-110713489-A | Heteroaryl SYK inhibitors | 2014-03-19 |
| EP-3119765-A1 | Heteroaryl syk inhibitors | 2014-03-19 |
| EP-3119765-B1 | Heteroaryl syk inhibitors | 2014-03-19 |
| EP-3119772-A1 | Heteroaryl sik inhibitors | 2014-03-19 |
| EP-3119772-B1 | Heteroaryl sik inhibitors | 2014-03-19 |
| ES-2738416-T3 | SYK heteroaryl inhibitors | 2014-03-19 |
| JP-2017511805-A | Heteroaryl SYK inhibitor | 2014-03-19 |
